Peng Z, Song J, Zhu W, Bao H, Hu Y, Shi Y
Mol Metab. 2025; 93:102109.
PMID: 39920992
PMC: 11869867.
DOI: 10.1016/j.molmet.2025.102109.
Zhang Y, Liao Q, Wen X, Fan J, Yuan T, Tong X
Mol Cancer. 2025; 24(1):44.
PMID: 39915765
PMC: 11800603.
DOI: 10.1186/s12943-025-02246-5.
Mahmoudian-Hamedani S, Lotfi-Shahreza M, Nikpour P
Biochem Biophys Rep. 2025; 41():101897.
PMID: 39807391
PMC: 11729012.
DOI: 10.1016/j.bbrep.2024.101897.
Owumi S, Chimezie J, Emmanuel P, Okeibuno A, Owoeye O
BMC Neurosci. 2024; 25(1):77.
PMID: 39722026
PMC: 11669237.
DOI: 10.1186/s12868-024-00922-8.
Wei T, Li R, Guo S, Liang C
Mol Med Rep. 2024; 30(6).
PMID: 39364731
PMC: 11484536.
DOI: 10.3892/mmr.2024.13351.
Neuroimmune modulation in liver pathophysiology.
Zou J, Li J, Wang X, Tang D, Chen R
J Neuroinflammation. 2024; 21(1):188.
PMID: 39090741
PMC: 11295927.
DOI: 10.1186/s12974-024-03181-w.
Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges.
Dang Q, Zuo L, Hu X, Zhou Z, Chen S, Liu S
Cancer Med. 2024; 13(14):e70041.
PMID: 39054866
PMC: 11272957.
DOI: 10.1002/cam4.70041.
The depth of perineural invasion is an independent prognostic factor for stage II colorectal cancer.
Chen H, Wang C, Chen Z, Huang T, Lin Y, Chen J
BMC Cancer. 2024; 24(1):433.
PMID: 38589842
PMC: 11003015.
DOI: 10.1186/s12885-024-12206-9.
Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis-associated adhesion of ovarian cancer cells.
Neuhaus F, Lieber S, Shinkevich V, Steitz A, Raifer H, Roth K
Clin Transl Med. 2024; 14(4):e1604.
PMID: 38566518
PMC: 10988119.
DOI: 10.1002/ctm2.1604.
Neuron-derived neurotensin promotes pancreatic cancer invasiveness and gemcitabine resistance via the NTSR1/Akt pathway.
Hung Y, Wang H, Hsu S, Wang L, Tsai Y, Su Y
Am J Cancer Res. 2024; 14(2):448-466.
PMID: 38455426
PMC: 10915311.
Metabolic underpinnings of cancer-related fatigue.
Zhang X, Perry R
Am J Physiol Endocrinol Metab. 2024; 326(3):E290-E307.
PMID: 38294698
PMC: 11901342.
DOI: 10.1152/ajpendo.00378.2023.
Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines.
Kuol N, Godlewski J, Kmiec Z, Vogrin S, Fraser S, Apostolopoulos V
BMC Cancer. 2023; 23(1):971.
PMID: 37828429
PMC: 10568879.
DOI: 10.1186/s12885-023-11410-3.
A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.
Zhao X, Wu X, Xiao J, Zhang L, Hao Y, Xiao C
iScience. 2023; 26(9):107497.
PMID: 37636041
PMC: 10450412.
DOI: 10.1016/j.isci.2023.107497.
Glial cell-derived soluble factors increase the metastatic potential of pancreatic adenocarcinoma cells and induce epithelial-to-mesenchymal transition.
Garcia-Reyes B, Kuzmanov I, Schneider R, Schneiker B, Efferz P, Kalff J
J Cancer Res Clin Oncol. 2023; 149(15):14315-14327.
PMID: 37572121
PMC: 10590291.
DOI: 10.1007/s00432-023-05133-y.
Advances in landscape and related therapeutic targets of the prostate tumor microenvironment.
Li D, Xu W, Chang Y, Xiao Y, He Y, Ren S
Acta Biochim Biophys Sin (Shanghai). 2023; 55(6):956-973.
PMID: 37294106
PMC: 10326416.
DOI: 10.3724/abbs.2023092.
Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease.
Spitschak A, Gupta S, Singh K, Logotheti S, Putzer B
Pharmaceutics. 2023; 15(1).
PMID: 36678712
PMC: 9865219.
DOI: 10.3390/pharmaceutics15010083.
Blocking Muscarinic Receptor 3 Attenuates Tumor Growth and Decreases Immunosuppressive and Cholinergic Markers in an Orthotopic Mouse Model of Colorectal Cancer.
Kuol N, Davidson M, Karakkat J, Filippone R, Veale M, Luwor R
Int J Mol Sci. 2023; 24(1).
PMID: 36614038
PMC: 9820315.
DOI: 10.3390/ijms24010596.
Predicting Tumor Perineural Invasion Status in High-Grade Prostate Cancer Based on a Clinical-Radiomics Model Incorporating T2-Weighted and Diffusion-Weighted Magnetic Resonance Images.
Zhang W, Zhang W, Li X, Cao X, Yang G, Zhang H
Cancers (Basel). 2023; 15(1).
PMID: 36612083
PMC: 9817925.
DOI: 10.3390/cancers15010086.
Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer.
Ephraim R, Feehan J, Fraser S, Nurgali K, Apostolopoulos V
Cancers (Basel). 2022; 14(24).
PMID: 36551617
PMC: 9776998.
DOI: 10.3390/cancers14246131.
Prediction and screening of circRNA in triple-negative breast cancer.
Li X, Zhang S, Sun S, Yue X, Qian L, Tang J
Am J Transl Res. 2022; 14(11):8049-8063.
PMID: 36505306
PMC: 9730078.